Table 1.
Target | Examples under clinical investigation ± ICB | References |
---|---|---|
PRR activation | Chemotherapy | Galluzzi et al, 2015 |
Radiation | Shabason and Minn, 2017 | |
HER2-directed antibody | Park et al, 2010, Stagg et al, 2011 | |
PRR agonists | Fu et al, 2015, Corrales et al, 2015, Charlebois et al, 2017, Kranz et al 2016, Shekarian et al, 2017 | |
Oncolytic viruses | Ribas et al, 2017 | |
Endogenous retroviruses | DNMT inhibitors | Chiappinelli et al, 2015; Roulois et al, 2015 Topper et al, 2017 |
HDAC inhibitors | ||
CDK4/6 inhibitors | Goel et al, 2017, Zhang et al, 2018 | |
Costimulatory agonist | CD40 agonist | Byrne and Vonderheide, 2016 |